Pretreatment of kaempferol-3-O-rutinoside protects H9c2 cells against LPS-induced inflammation through the AMPK/SIRT1 pathway
Main Article Content
Keywords
AMPK/SIRT1 signaling pathway, inflammation, kaempferol-3-O-rutinoside, myocardial protection
Abstract
Kaempferol-3-O-rutinoside (KR) is a flavonoid glycoside derived from traditional Chinese medicine, plants, and tea, and has good myocardial protection. This study focuses on the mechanism of myocardial protection with KR and whether myocardial protection can be achieved by activating the adenosine monophosphate-activated protein kinase–silent mating-type information regulation 2 homolog 1 (sirtuin) (AMPK/SIRT1) signal pathway. Molecular docking technique was used to predict the binding affinity of KR to AMPK. The inflammatory injury model of H9c2 cells was established by lipopolysaccharide (LPS) induction. H9c2 cell proliferation was detected by cell counting kit -8 assay. The apoptosis rate was measured by flow cytometry. Levels of interlukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α) were determined by enzyme-linked-immunosorbent serologic assay. AMPK and SIRT1 expression levels were quantified through reverse transcription-polymerase chain reaction and Western blotting assay. Results indicated that KR has a certain binding affinity with AMPK. KR could increase the growth of H9c2 inhibited by LPS, reduce apoptosis rate, and reverse the elevated levels of IL-1β, IL-6, and TNF-α. Furthermore, KR could suppress the expression levels of AMPK and SIRT1, and AMPK-specific inhibitor (Compound C) could significantly counteract the activation of KR, indicating that its anti-inflammatory effect is achieved by regulating the AMPK/SIRT1 signaling pathway.
References
Chen R., Gao S., Guan H., Zhang X., Gao Y., Su Y., et al. 2022. Naringin protects human nucleus pulposus cells against TNF-α-induced inflammation, oxidative stress, and loss of cellular homeostasis by enhancing autophagic flux via AMPK/SIRT1 activation. Oxid Med Cell Longev. 2022: 7655142. 10.1155/2022/7655142
Chen X., Li X., Zhang W., He J., Xu B., Lei B., et al. 2018. Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-κB pathway. Metabolism. 83: 256–270. 10.1016/j.metabol.2018.03.004
Chen C., Zhou M., Ge Y. and Wang X. 2020. SIRT1 and aging related signaling pathways. Mech Ageing Dev. 187: 111215. 10.1016/j.mad.2020.111215
D’Alessandra Y., Chiesa M., Carena M.C., Beltrami A.P., Rizzo P., Buzzetti M., et al. 2020. Differential role of circulating microRNAs to track progression and pre-symptomatic stage of chronic heart failure: A pilot study. Biomedicines. 8(12): 597. 10.3390/biomedicines8120597
Deng H.J., Zhou C.H., Huang L.T., Wen L.B., Zhou M.L. and Wang C.X. 2021. Activation of silent information regulator 1 exerts a neuroprotective effect after intracerebral hemorrhage by deacetylating NF-κB/p65. J Neurochem. 157(3): 574–585. 10.1111/jnc.15258
Herzig S. and Shaw R.J. 2018. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 19(2): 121–135. 10.1038/nrm.2017.95
Hua F., Li J.Y., Zhang M., Zhou P., Wang L., Ling T.J., et al. 2022. Kaempferol-3-O-rutinoside exerts cardioprotective effects through NF-κB/NLRP3/Caspase-1 pathway in ventricular remodeling after acute myocardial infarction. J Food Biochem. 46(10): e14305. 10.1111/jfbc.14305
Hua F., Zhou P., Liu P.P. and Bao G.H. 2021. Rat plasma protein binding of kaempferol-3-O-rutinoside from Lu’an GuaPian tea and its anti-inflammatory mechanism for cardiovascular protection. J Food Biochem. 45(7): e13749. 10.1111/jfbc.13749
Hua F., Zhou P., Wu H.Y., Chu G.X., Xie Z.W. and Bao G.H. 2018. Inhibition of α-glucosidase and α-amylase by flavonoid glycosides from Lu’an GuaPian tea: molecular docking and interaction mechanism. Food Func. 9(8): 4173–4183. 10.1039/C8FO00562A
Hurley D.J., Irnaten M. and O’Brien C. 2021. Metformin and glaucoma-review of anti-fibrotic processes and bioenergetics. Cells. 10(8): 2131. 10.3390/cells10082131
Li Y., Yu X., Wang Y., Zheng X. and Chu Q. 2021. Kaempferol-3-O-rutinoside, a flavone derived from Tetrastigma hemsleyanum, suppresses lung adenocarcinoma via the calcium signaling pathway. Food Func. 12(18): 8351–8365. 10.1039/D1FO00581B
Liu Y., Grimm M., Dai W.T., Hou M.C., Xiao Z.X. and Cao Y. 2020. CB-Dock: a web server for cavity detection-guided protein-ligand blind docking. Acta Pharmacol Sin. 41(1): 138–144. 10.1038/s41401-019-0228-6
Schumacher D., Alampour-Rajabi S., Ponomariov V., Curaj A., Wu Z., Staudt M., et al. 2019. Cardiac FGF23: new insights into the role and function of FGF23 after acute myocardial infarction. Cardiovasc Pathol. 40: 47–54. 10.1016/j.carpath.2019.02.001
Sun J.H., Yang H.X., Yao T.T., Li Y., Ruan L., Xu G.R., et al. 2021. Gentianella acuta prevents acute myocardial infarction induced by isoproterenol in rats via inhibition of galectin-3/TLR4/MyD88/NF-кB inflammatory signalling. Inflammopharmacology. 29(1): 205–219. 10.1007/s10787-020-00708-4
Tang T.J., Wang X., Wang L., Chen M., Cheng J., Zuo M.Y., et al. 2022. Liquiritin inhibits H2O2-induced oxidative stress injury in H9c2 cells via the AMPK/SIRT1/NF-κB signaling pathway. J Food Biochem. 46(10): e14351. 10.1111/jfbc.14351
Wang Y., Tang C. and Zhang H. 2015. Hepatoprotective effects of kaempferol 3-O-rutinoside and kaempferol 3-O-glucoside from Carthamus tinctorius L. on CCl4-induced oxidative liver injury in mice. J Food Drug Anal. 23: 310–317. 10.1016/j.jfda.2014.10.002
Wang S., Ye L. and Wang L. 2019. Protective mechanism of shenmai on myocardial ischemia-reperfusion through the energy metabolism pathway. Am J Transl Res. 11(7): 4046–4062.
Wang Y., Zhang S., Ni H., Zhang Y., Yan X., Gao Y., et al. 2021. Autophagy is involved in the neuroprotective effect of nicotiflorin. J Ethnopharmacol. 278: 114279. 10.1016/j.jep.2021.114279
Wu K.K. 2021. Control of mesenchymal stromal cell senescence by tryptophan metabolites. Int J Mol Sci. 22(2): 697. 10.3390/ijms22020697
Wu S. and Zou M.H. 2020. AMPK, mitochondrial function, and cardiovascular disease. Int J Mol Sci. 21(14): 4987. 10.3390/ijms21144987
Xiao B., Sanders M.J., Carmena D., Bright N.J., Haire L.F., Underwood E., et al. 2013. Structural basis of AMPK regulation by small molecule activators. Nat Commun. 4: 3017.10.1038/ncomms4017
Yu S., Guo Q., Jia T., Zhang X., Guo D., Jia Y., et al. 2021. Mechanism of action of nicotiflorin from Tricyrtis maculata in the treatment of acute myocardial infarction: from network pharmacology to experimental pharmacology. Drug Des Devel Ther. 15: 2179–2191. 10.2147/DDDT.S302617
Yuan Q., Zhang X., Wei W., Zhao J., Wu Y., Zhao S., et al. 2022. Lycorine improves peripheral nerve function by promoting Schwann cell autophagy via AMPK pathway activation and MMP9 downregulation in diabetic peripheral neuropathy. Pharmacol Res. 175: 105985. 10.1016/j.phrs.2021.105985
Zhao D., Liu J., Wang M., Zhang X. and Zhou M. 2019. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 16(4): 203–212. 10.1038/s41569-018-0119-4
Zhao F., Meng Y., Wang Y., Fan S., Liu Y., Zhang X., et al. 2022. Protective effect of Astragaloside IV on chronic intermittent hypoxia-induced vascular endothelial dysfunction through the calpain-1/SIRT1/AMPK signaling pathway. Front Pharmacol. 13: 920977. 10.3389/fphar.2022.920977
Zhao Y., Sun H., Li K., Shang L., Liang X., Yang H., et al. 2021. Cholinergic elicitation prevents ventricular remodeling via alleviations of myocardial mitochondrial injury linked to inflammation in ischemia-induced chronic heart failure rats. Mediators Inflamm. 2021: 4504431. 10.1155/2021/4504431